Explore
Biosimilars in Europe
0 Ungluers have
Faved this Work
Login to Fave
This reprint examines regulatory, pricing and reimbursement issues related to the market access and uptake of off-patent biologics, biosimilars, next-generation biologics and competing innovative medicines in European countries.
This book is included in DOAB.
Why read this book? Have your say.
You must be logged in to comment.